HIV prevalence in Botswana is 17.1%, President Mogae says

NewsGuard 100/100 Score

HIV prevalence in Botswana is 17.1%, lower than figures previously reported by UNAIDS, Botswana President Festus Mogae said Monday, Xinhua/People's Daily reports.

"The figures that used to be used by the U.N. were based on sample surveys on expectant women, which were not adequately represented," Mogae said (Xinhua/People's Daily, 10/18).

The country's Ministry of Health has said that about 38.5% of the adult population is HIV-positive, while a 2006 UNAIDS report said the country's adult HIV prevalence is about 24%.

International advocacy groups report that life expectancy in the country has decreased to an average of 34 years, and CIA data show that the country has a negative population growth curve (Kaiser Daily HIV/AIDS Report, 9/28).

According to Mogae, more than 75,000 people in Botswana are HIV-positive, and more than 68,000 of them are receiving antiretroviral treatment with government assistance (Xinhua News Agency, 10/18).

Botswana also has changed its HIV testing policy so that routine testing is conducted in clinics and hospitals and people are given the option to opt out of testing (Kaiser Daily HIV/AIDS Report, 10/13).

Mogae said an increasing number of women are receiving HIV tests, with about 85% to 90% of pregnant women agreeing to be tested and large numbers agreeing to receive antiretrovirals.

"As a result of the increased compliance, the number of babies born to HIV-positive mothers has fallen from 40% to a registered 6%. That has been a dramatic improvement," Mogae said (Xinhua/People's Daily, 10/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication